Stock ITOS ITEOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/07/2024 BST 		5-day change 1st Jan Change
17.01 USD -3.13% Intraday chart for iTeos Therapeutics, Inc. +11.54% +55.34%
07-08 ITeos Therapeutics Doses First Patient in Phase 3 Trial of Belrestotug With Dostarlimab; Triggers $35 Million GSK Payment MT
07-08 ITeos Therapeutics, Inc. Announces First Patient Dosed in Galaxies Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ITEOS THERAPEUTICS, INC.
Bio Therapeutic Drugs
-3.13%+11.54%+55.34%+21.41% - 654M
Bullish
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. ITOS Stock
  4. Charts iTeos Therapeutics, Inc.
  5. Relative Strength Chart